Login to Your Account



Addex Raises CHF50.5M For Development Of CNS Drugs

By Cormac Sheridan


Wednesday, May 19, 2004
Addex Pharmaceuticals SA raised CHF50.5 million (US$39.6 million) in what it called Europe's largest-ever Series B financing round for a biotechnology company. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription